R07 Stock Chart & Stats
€0.27
<€0.01(3.01%)
At close: 4:00 PM EDT
€0.27
<€0.01(3.01%)
Day’s Range― - ―
52-Week Range€0.25 - €0.40
Previous CloseN/A
Volume0.00
Average Volume (3M)130.00
Market Cap
€20.21M
Enterprise Value€46.33
Total Cash (Recent Filing)€2.96M
Total Debt (Recent Filing)€15.58M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Nov 18, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding67,578,920
10 Day Avg. Volume380
30 Day Avg. Volume130
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)0.71
Price to Sales (P/S)0.53
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.71Price Target Upside164.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)€45.38M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRecord quarterly revenue and strong sequential growth indicate improving demand and distribution for Rubicon’s premium portfolio. If sustained, higher volumes can support better fixed-cost absorption, strengthen brand economics, and provide a foundation for continued expansion across Canadian and international channels.
Yield And Capacity ExpansionHigher per-crop yields directly improve productive efficiency and can increase available product without proportionate facility expansion. Combined with the planned capacity increase, these operational gains could support revenue growth, improve cost absorption, and enhance the scalability of Rubicon’s cultivation platform.
Premium Brand PositionLeadership in premium flower share and concentration in a recognized flagship brand provide evidence of consumer traction in Rubicon’s target segment. A stronger branded mix can support differentiation, customer loyalty, and potentially better pricing quality than reliance on undifferentiated wholesale products.
Bears Say
Gross Margin CompressionThe sharp deterioration in gross and operating margins shows that recent revenue growth is not yet translating into durable profitability. Persistent cost or mix pressure would limit reinvestment capacity, weaken cash conversion, and make future earnings dependent on successful operational improvements rather than scale alone.
Negative Cash GenerationNegative operating and free cash flow indicate that the business is not currently funding its operations and investment needs internally. The limited cash balance increases the importance of disciplined spending and successful execution, while prolonged cash burn could restrict growth initiatives or increase reliance on external financing.
Cascadia Ramp RiskCascadia has not yet reached its targeted yield performance, delaying the facility’s expected contribution to volume and margins. Because the growth plan depends on scaling this asset, slower optimization could extend start-up costs, reduce near-term profitability, and postpone the operating leverage management expects from added capacity.
Rubicon Organics News
R07 FAQ
What was Rubicon Organics Inc’s price range in the past 12 months?
Rubicon Organics Inc lowest stock price was €0.25 and its highest was €0.40 in the past 12 months.
What is Rubicon Organics Inc’s market cap?
Rubicon Organics Inc’s market cap is €20.21M.
When is Rubicon Organics Inc’s upcoming earnings report date?
Rubicon Organics Inc’s upcoming earnings report date is Nov 18, 2026 which is in 54 days.
How were Rubicon Organics Inc’s earnings last quarter?
Rubicon Organics Inc released its earnings results on Aug 11, 2026. The company reported €0.006 earnings per share for the quarter, beating the consensus estimate of -€0.003 by €0.009.
Is Rubicon Organics Inc overvalued?
According to Wall Street analysts Rubicon Organics Inc’s price is currently Undervalued.
Does Rubicon Organics Inc pay dividends?
Rubicon Organics Inc does not currently pay dividends.
What is Rubicon Organics Inc’s EPS estimate?
Rubicon Organics Inc’s EPS estimate is <0.01.
How many shares outstanding does Rubicon Organics Inc have?
Rubicon Organics Inc has 67,578,920 shares outstanding.
What happened to Rubicon Organics Inc’s price movement after its last earnings report?
Rubicon Organics Inc reported an EPS of €0.006 in its last earnings report, beating expectations of -€0.003. Following the earnings report the stock price went down -10.909%.
Which hedge fund is a major shareholder of Rubicon Organics Inc?
Currently, no hedge funds are holding shares in DE:R07
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rubicon Organics Inc
Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.
R07 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated clear operational momentum (record revenue, 20% yield gains at Pacifica, Cascadia brought online and certified, market share gains, and margin improvement potential excluding Cascadia start-up costs) alongside typical early-stage scaling challenges (Cascadia yields below targets, modest Q2 Cascadia revenue, higher SG&A, slight YoY decline in adjusted EBITDA, and limited cash). Management offered a coherent plan (yield optimization, in-house extraction, automation, portfolio optimization, international expansion) and expects margin and EBITDA ramp in H2 2026 into 2027. Overall, positives (revenue growth, operational wins, brand strength, certifications) materially outweigh the near-term costs and execution risks.View all DE:R07 earnings summariesR07 Stock 12 Month Forecast
Average Price Target
€0.71
▲(164.71% Upside)